Renal Replacement Therapy (2017-05-01)

Policy for developing clinical practice guidelines of Japanese Society for Dialysis Therapy

  • Kosaku Nitta,
  • Ikuto Masakane,
  • Tadashi Tomo,
  • Kenji Tsuchida,
  • Kiyoshi Ikeda,
  • Tomonari Ogawa,
  • Eiichiro Kanda,
  • Yoshihiko Kanno,
  • Yasuhiro Komatsu,
  • Masatomo Taniguchi,
  • Fumika Taki,
  • Takeshi Hasegawa,
  • Norio Hanafusa,
  • Takayuki Hamano,
  • Masafumi Fukagawa,
  • Jun Minakuchi,
  • Hiroyasu Yamamoto,
  • Naoki Washida,
  • Takashi Wada,
  • Yuzo Watanabe,
  • on behalf of the Scientific Academy Committee of Japanese Society for Dialysis Therapy (JSDT)

Journal volume & issue
Vol. 3, no. 1
pp. 1 – 11


Read online

Abstract Background The Scientific Academy Committee of Japanese Society for Dialysis Therapy (JSDT) has developed 14 clinical practice guidelines (CPGs) and their revised editions independently or in cooperation with other organizations and translated many of them into English to make them available to the world. These guidelines were presented in a user-friendly textbook-like format and were useful for many healthcare professionals engaged in dialysis therapy. However, because the definition and the process for developing CPGs have recently become more rigorous worldwide, the conventional process of development and the format of JSDT no longer meet the requirements for CPGs. Method Since 2012, JSDT, with its Guideline Developing Working Group (formerly Guideline Subcommittee), had evaluated several CPGs developing systems. The working group evaluated the advantages and disadvantages of several CPGs developing systems. The most important point of them which JSDT would adopt for their own system was to be based on evidence and be able to receive international recognition. Results In Grading of Recommendations, Assessment, Development, and Evaluations (GRADE) system, the quality of evidence was evaluated by systematic review on each clinical outcome by systematic review panel. After the report from the systematic review panel, the CPG panel grades the strength of recommendation on each CPG statement. GRADE system was the most frequently used for developing CPGs by many human healthcare societies in the world. If JSDT adopt GRADE system, it is necessary for us to learn how to assess the quality of evidence through a systematic review, to develop a system for determining the strength of recommendation on the basis of a systematic review, and to decide how to manage any conflicts of interest. Conclusions JSDT should provide the useful information from Japanese experiences on chronic dialysis to the world. In order to achieve this aim, we concluded that the most reasonable approach is to utilize the data from JSDT Renal Data Registry in a more creative manner, publish such data for the world as evidence, and develop CPGs in accordance with a globally recognized methodology, GRADE. Notification The current manuscript is the position statement of JSDT for developing future CPGs and the second publication of “Policy for Developing Clinical Practice Guidelines (CPGs) of the Japanese Society for Dialysis Therapy” on J Jpn Soc Dial Ther 2016; 49: 453-62 (in Japanese), with permission.